Detailed studies using genetically engineered and/or syngeneic murine models of metastatic osteosarcoma are necessary to experimentally elucidate the functional impact of CXCR4 signaling and its candidacy as a therapeutic target in this disease context. Here, CXCR4 is linked to osteosarcoma.